Sensyne Health PLC Appointment of Joint Broker and Financial Adviser (6694Q)
22 Ottobre 2019 - 08:00AM
UK Regulatory
TIDMSENS
RNS Number : 6694Q
Sensyne Health PLC
22 October 2019
Appointment of Liberum as Joint Broker and Financial Adviser
Oxford, UK; 22 October 2019: Sensyne Health plc (LSE: SENS), the
British clinical AI technology company, announces that it has
appointed Liberum Capital Limited ("Liberum") as joint broker and
financial adviser, with immediate effect, alongside Peel Hunt who
are joint broker and joint financial adviser and nominated adviser
to the Company.
-ENDS-
For more information please contact:
+44 (0) 330 058
Sensyne Health (www.sensynehealth.com) 1845
Lord (Paul) Drayson, Chief Executive Officer
Lorimer Headley, Chief Financial Officer
Peel Hunt LLP (Nominated Adviser and Joint + 44 (0) 20 7418
Broker) 8900
Dr Christopher Golden
James Steel
Oliver Jackson
+ 44 (0) 20 3100
Liberum (Joint Broker) 2000
Bidhi Bhoma
Euan Brown
Consilium Strategic Communications +44 20 3709 5700
Mary-Jane Elliott
Sukaina Virji
Melissa Gardiner
sensynehealth@consilium-comms.com
About Sensyne Health
Sensyne Health plc is a healthcare technology company that
creates value from accelerating the discovery and development of
new medicines and improving patient care through the analysis of
real-world evidence from large databases of anonymised patient data
in collaboration with NHS Trusts. These anonymised patient data are
ethically sourced in that any analysis of anonymised patient data
(and hence the Company's access to it) must be pre-approved for
each programme on a case-by-case basis by the relevant NHS Trusts.
This is to ensure that the purpose of the anonymisation and the
proposed analysis are subject to appropriate ethical oversight and
information governance, including conformance with NHS principles,
UK data protection law and applicable regulatory guidance. Sensyne
Health is an early signatory to the Department of Health and Social
Care's 'Initial Code of Conduct for data-driven health and care
technology.
Sensyne Health is listed on the AIM Market of the London Stock
Exchange (SENS.L).
For more information, please visit: www.sensynehealth.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
APPGMMZGKZZGLZG
(END) Dow Jones Newswires
October 22, 2019 02:00 ET (06:00 GMT)
Grafico Azioni Sensyne Health (LSE:SENS)
Storico
Da Feb 2024 a Mar 2024
Grafico Azioni Sensyne Health (LSE:SENS)
Storico
Da Mar 2023 a Mar 2024
Notizie in Tempo Reale relative a Sensyne Health Plc (Borsa di Londra): 0 articoli recenti
Più Sensyne Health Plc Articoli Notizie